Correlation Between CRISPR Therapeutics and PulteGroup,

Can any of the company-specific risk be diversified away by investing in both CRISPR Therapeutics and PulteGroup, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CRISPR Therapeutics and PulteGroup, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between CRISPR Therapeutics AG and PulteGroup,, you can compare the effects of market volatilities on CRISPR Therapeutics and PulteGroup, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CRISPR Therapeutics with a short position of PulteGroup,. Check out your portfolio center. Please also check ongoing floating volatility patterns of CRISPR Therapeutics and PulteGroup,.

Diversification Opportunities for CRISPR Therapeutics and PulteGroup,

0.75

Correlation Coefficient

CRISPR Therapeutics  PulteGroup,

Poor diversification

The 3 months correlation between CRISPR and PulteGroup, is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding CRISPR Therapeutics AG and PulteGroup, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PulteGroup, and CRISPR Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CRISPR Therapeutics AG are associated (or correlated) with PulteGroup,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PulteGroup, has no effect on the direction of CRISPR Therapeutics i.e., CRISPR Therapeutics and PulteGroup, go up and down completely randomly.

Pair Corralation between CRISPR Therapeutics and PulteGroup,

Assuming the 90 days trading horizon CRISPR Therapeutics AG is expected to generate 2.21 times more return on investment than PulteGroup,. However, CRISPR Therapeutics is 2.21 times more volatile than PulteGroup,. It trades about -0.03 of its potential returns per unit of risk. PulteGroup, is currently generating about -0.11 per unit of risk. If you would invest  3,450  in CRISPR Therapeutics AG on October 25, 2024 and sell it today you would lose (322.00) from holding CRISPR Therapeutics AG or give up 9.33% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

CRISPR Therapeutics AG  vs.  PulteGroup,

CRISPR Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days CRISPR Therapeutics AG has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

PulteGroup,

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days PulteGroup, has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's technical indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Pair Trading with CRISPR Therapeutics and PulteGroup,

The main advantage of trading using opposite CRISPR Therapeutics and PulteGroup, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CRISPR Therapeutics position performs unexpectedly, PulteGroup, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PulteGroup, will offset losses from the drop in PulteGroup,'s long position.

The idea behind CRISPR Therapeutics AG and PulteGroup, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.